Clinical
RSSArticles
-
The Benefits of a Diet Rich in Omega 3s
Your patients' benefits and risks of eating fish rich in omega-3 fatty acids.
-
Pistachios and Metabolic Risk Factors
This study is a randomized, crossover clinical trial demonstrating that a pistachio-rich diet significantly reduced fasting glucose, insulin, and insulin resistance compared to the control diet group in prediabetic individuals.
-
Clinical Briefs
Topics: Metformin: Have we Been Overcautious in CKD?, Reduction in Prostate, and Doing the Right Thing for Acute Bronchitis in Healthy Adults: Antibiotics
-
Edoxaban Tablets (Savaysa™)
The third oral factor Xa inhibitor has been approved by the FDA. Edoxaban is the fourth target-specific oral anticoagulant (TSOA) to enter the market following dabigatran (Pradaxa), rivaroxaban (Xarelto), and apixaban (Eliquis). Edoxaban is manufactured by Tokyo-based Daiichi Sankyo Company and marketed by Daiichi Sankyo as Savaysa.
-
The Economic Burden of Undiagnosed Pre-diabetes
The economic burden of diagnosed and undiagnosed diabetes, gestational diabetes, and prediabetes has exceeded $322 billion.
-
Treatment of C. Difficile — Follow the Guidelines
ABSTRACT & COMMENTARY: The primary outcome was the occurrence of complications, including relapse within four weeks, surgery, and 30-day mortality.
-
Should Clinicians Discuss Resumption of Sexual Activity Following an Acute MI?
Although the U.S. and European cardiovascular society guidelines recommend that patients be counseled about resuming sexual activity after suffering an acute myocardial infarction (AMI), the actual demographics of sexual education post-myocardial infarction (MI) are unknown.
-
The Whole Is Greater than the Parts: Artemisia Annua and Malaria
Whole plant Artemisia annua more adequately treated one species of the malaria parasite infection in mice.
-
Statins and the Neuromuscular System
Statins inhibit the function of 3-hydroy-3-methylglutaryl coenzyme A reductase and are widely used for risk reduction of cardiovascular and cerebrovascular disease. It is estimated that about 10% of patients will discontinue statins due to muscle-related symptoms.
-
Predicting Efficacy of IVIG in CIDP
In a retrospective chart review of 281 treatment-naïve patients with chronic inflammatory demyelinating polyradiculoneuropathy, lack of response to intravenous immunoglobulin was predicted by 1) presence of painful neuropathy and 2) strength differences between arm and leg muscles.